503315-74-0

Basic information

• Product Name: 3-Fluoro-4-nitrobenzyl alcohol 99%
• Synonyms: 3-Fluoro-4-nitrobenzyl alcohol 99%;(3-Fluoro-4-nitrophenyl)methanol, 2-Fluoro-4-(hydroxymethyl)nitrobenzene;3-Fluoro-4-nitrobenzenemethanol;3-Fluoro-4-nitrobenzylalcohol98%;(3-Fluoro-4-nitrophenyl);Structure
• CAS NO: 503315-74-0
• Molecular Formula: C₇H₆FNO₃
• Molecular Weight: 171.1258432
• Mol File: 503315-74-0.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 328.6±27.0 °C(Predicted)
• Appearance: /
• Density: 1.434
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 13.27±0.10(Predicted)
• CAS DataBase Reference: 3-Fluoro-4-nitrobenzyl alcohol 99%(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Fluoro-4-nitrobenzyl alcohol 99%(503315-74-0)
• EPA Substance Registry System: 3-Fluoro-4-nitrobenzyl alcohol 99%(503315-74-0)

Safety Data

• Hazardous Substances Data: 503315-74-0(Hazardous Substances Data)

Usage

General Description

3-Fluoro-4-nitrobenzyl alcohol 99% is a chemical compound that primarily behaves as an organic intermediate. Its molecular formula is C7H6FNO3 and it presents as solid pieces or powder in its physical state. The 99% signifies its purity level, implying that it is in a nearly pure form. It has practical applications in scientific research primarily in the formulation of other advanced compounds or materials. It's necessary to handle it with care due to its reactivity with specific substances and its potential to cause harm if mishandled. This chemical exists as a single isomer due to the explicit locations of the substituent groups (fluoro-, nitro-, and benzyl alcohol) around the benzene ring.

Upstream product

• 185629-31-6 methyl 3-fluoro-4-nitrobenzoate 
• 403-21-4 3-fluoro-4-nitrobenzoic acid 

Downstream Products

• 1225287-21-7 3-fluoro-4-nitrobenzyl phosphoramide mustard 
• 918155-87-0 C₃₃H₃₅N₅O₃ 
• 918155-73-4 C₃₄H₃₇N₅O₃ 
• 918155-83-6 C₂₉H₃₇N₅O₂Si 
• 918155-82-5 C₂₉H₃₄Cl₃N₃O₂Si 
• 918155-78-9 C₂₉H₃₅N₃O₄Si 
• 918155-74-5 C₂₈H₃₅N₃O₃Si 
• 918155-69-8 C₂₇H₃₇N₃O₂Si 
• 918155-84-7 C₂₃H₂₃N₅O₂ 
• 918155-71-2 C₂₄H₂₄N₄O₃ 
• 918155-85-8 C₂₃H₂₂N₄O₃ 
• 918155-79-0 C₂₃H₂₁N₃O₄ 
• 918155-72-3 C₂₄H₂₂N₄O₃ 
• 918155-86-9 C₂₃H₂₀N₄O₃ 

Relevant articles and documents

Synthesis route and preparation method of 3-fluorine-4-nitrobenzaldehyde

The invention discloses a new synthetic route of 3-fluorine-4-nitrobenzaldehyde and a preparation method thereof. The preparation method comprises the following steps: adding 3-fluorine-4-nitrobenzoicacid and an acidic catalyst into an organic solvent methanol, stirring at 60 to 80 DEG C for 5 to 12 hours, and carrying out after-treatment to obtain a solid intermediate product 2; adding the intermediate product 2 into an organic solvent II, adding sodium borohydride while uniformly stirring at 0 DEG C, stirring for 0.5 to 1h at 0 DEG C, slowly heating to 60 DEG C, stirring for 2 to 6h, stopping stirring, and carrying out post-treatment to obtain an intermediate product 3; and adding the intermediate product 3 and an oxidant III into an organic solvent IV, heating and refluxing for 3 to 10hours, cooling to 20 to 30 DEG C after the reaction is finished, and carrying out post-treatment on the reaction solution to obtain the product 3-fluorine-4-nitrobenzaldehyde. According to the methoddisclosed by the invention, sodium borohydride which is safe and easy to treat is adopted to replace high-activity ultralow-temperature anhydrous oxygen diisobutyl aluminum hydride for reduction reaction, so that a relatively good effect is achieved, and the compound 3-fluorine-4-nitrobenzaldehyde is safely and efficiently synthesized. The method is simple, the requirements of production equipment are reduced, the cost is controlled, and the method is suitable for industrial production.

Synthesis and Biological Characterization of Aryl Uracil Inhibitors of Hepatitis C Virus NS5B Polymerase: Discovery of ABT-072, a trans-Stilbene Analog with Good Oral Bioavailability

ABT-072 is a non-nucleoside HCV NS5B polymerase inhibitor that was discovered as part of a program to identify new direct-acting antivirals (DAAs) for the treatment of HCV infection. This compound was identified during a medicinal chemistry effort to impr

COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATMENT OF PROTOZOAN INFECTIONS

Provided are compounds, compositions and methods for treating protozoan infections.